Targeting Microbiota 2024: Towards clinical revolution with outstanding speakers and topics this October in Malta

The International Society of Microbiota is pleased to announce the agenda of the 11^th World Congress on Targeting Microbiota, set to take place on October 14-15, 2024, at the Corinthia Palace in Malta. This year's congress, "Targeting Microbiota: Towards Clinical Revolution", promises to be a groundbreaking event, bringing together leading experts to discuss the latest advancements and future directions in microbiota research and its clinical applications.

Key Highlights:

• Day 1 Keynote Address: Mzia Kutateladze from the Eliava Institute of Bacteriophage will present on “Targeting Gut and Skin by Phages: Towards the Next Clinical Revolution”.
• Day 2 Keynote Address: Marvin Edeas from INSERM U1016, Université de Paris, will explore “The Mystery of the Microbiome Genome: The Potential of 2 to 20 Million Microbial Genes to Transform Our Health”.

 

Outstanding Speakers and Topics to be Answered and Discussed:

1. Clinical Revolution in Microbiota Research:

• How can targeting gut and skin by phages lead to the next clinical revolution?
• What are the latest advancements in gut microbiome related to obesity and diabetes?

2. Gut-Brain Axis & Depression:

• What is the strategic role of dietary profiles in the gut-brain axis and depression?

3. Microbiota-Derived Extracellular Vesicles:

• How do extracellular vesicles bridge communication between mother and fetus?

4. Bacteriophage Therapy:

• How can bacteriophages be redesigned to support infectious disease therapy?

5. Microbiome and Early Life:

• What impact does gut microbiota have on neurodevelopmental outcomes in early life?

6. Oral-Placental Microbiome:

• What is the significance of the oral-placental microbiome axis in preterm birth?

7. Microbiomes and Metagenomes:

• How can we identify, produce, and apply bacteriocins from microbiomes and metagenomes?

8. Male Fertility and Gut Microbiota:

• What is the current knowledge and future direction in the relationship between male fertility and gut microbiota?

9. IBS and Gut Microbiome:

• What are the signatures of the gut microbiome in irritable bowel syndrome?

 

Key Questions and What’s Next?

1. Microbiome Genomics: How can we unlock the potential of microbial genes to transform health?
2. Mythbusting the Microbiome: What are the common misconceptions about the microbiome, and how can we address them?
3. Probiotics and Health: How do we select the right probiotic strain for health benefits?
4. Small Intestinal Microbiota: What impact does targeting the small intestinal microbiota have on metabolism?
5. Microbial Phenotypes in Obesity: What are the implications of microbial phenotypes for precision nutrition in obesity?
6. Natural Riboflavin Analogues: How can natural riboflavin analogues be used to modify the human microbiota?
7. Advanced Models of the Gut Microbiota: What are the benefits and limitations of sophisticated in vitro models of the gastrointestinal tract?
8. Microbiota and Heart Healing: How do gut bacteria contribute to post-infarction resilience and heart healing?
9. Microbiota and Hypertension: What are the prospects for leveraging the microbiota as medicine for hypertension?

 

Join Targeting Microbiota 2024 in Malta this October to know more about all recent advances and innovations in the field.

For more information about the meeting speakers, attendees, and scientific content, please visit: www.microbiota-ism.com.

 

About the International Society of Microbiota (ISM)

The ISM was established in 2013, evolving from the Task Force Mitochondria-Microbiota to encompass experts in the field of microbiota. The ISM aims to accelerate the credible translation of microbiota science into real benefits for consumers. It also encourages communication and interaction among researchers, physicians, nutritionists, industry professionals, and strategic marketing managers through a global microbiota network, particularly during its annual world meeting.

---

---